Drug Profile
OPN 21
Alternative Names: OPN-21Latest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator OptiNose
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Narcolepsy
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for research development in Narcolepsy in United Kingdom (Intranasal, Powder)
- 26 Jan 2017 Early research in Narcolepsy in United Kingdom (Intranasal)